org placeholder image

Vassiliki Karantza

Individualized Neoantigen Therapy (Int)-V940 Asset Lead at Merck

  • LinkedIn

Email Email: v****@merck.com

phone noPhone Number: (***)-***-****

map
MERCK

MERCK

  • Employees count Employees 10001+
  • Revenue Revenue 1 Billion and Over
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Merck Org Chart and Mapping

Employees

Felipe Diaz

Director, External Manufacturing Quality Assurance

Shelley Hancox

Executive Director Strategic Programs - Gsmg and Gwes

Ronald Chang

Associate Director Strategic Communications Lead and Product Marketing Manager

Mike Brown

Oncology Sales Specialist

Bozena Sadej

Assoc. Director, Clinical Data MGMT

Mark Xue

Clinical Programming

Frequently Asked Questions Regarding Vassiliki Karantza

Answer: Vassiliki Karantza works for Merck as Individualized Neoantigen Therapy (Int)-V940 Asset Lead

Answer: Vassiliki Karantza’s role in Merck is Individualized Neoantigen Therapy (Int)-V940 Asset Lead

Answer: Vassiliki Karantza's email address is v***@gmail.com

Answer: Vassiliki Karantza's business email address is v****@merck.com

Answer: Vassiliki Karantza’s direct phone number is (***)-***-****

Answer: Vassiliki Karantza works in the industry of: Pharmaceuticals

Answer: Vassiliki Karantza works Merck located at 126 E Lincoln Ave, Rahway, New Jersey, 07065, United States

Answer: Merck's Individualized Neoantigen Therapy (Int)-V940 Asset Lead is Vassiliki Karantza

Answer: Vassiliki Karantza contact details:

  • Phone number  :  (***)-***-****
  • Email  :  v****@merck.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access